Clinical trial
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and…
NCT00194402 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00194402 |
|---|---|
| Title | SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia |
| Official title | SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers |
| Lead sponsor | University of Washington, Other |
| Collaborators | Upsher-Smith Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyslipidemia |
| Intervention type | Drug |
| Interventions | Slo-Niacin, atorvastatin |
| Enrollment | 64 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: